1 Lung Cancer Research: From Prevention to Cure! Ravi Salgia, M.D, Ph.D Associate Professor of Medicine Director, Thoracic Oncology Research Program Department of Medicine Section of Hematology/Oncology University of Chicago Cancer Research Center University of Chicago Pritzker School of Medicine
2 Introduction Lung cancer is one of the most common cancer worldwide. There will be >170,000 diagnosed cases of lung cancer in There will be >160,000 deaths from lung cancer in About 75-80% of lung cancers are associated with smoking However, over 50% have stopped smoking. AND over 15-20% NEVER smoked.
3 Lung Cancer: More Research Needed Every three minutes someone is diagnosed with lung cancer Men have a lifetime risk of 1 in 13 and women 1 in 17 In 2003, the federal government spent $14,045/breast cancer death, $10,761/prostate cancer death, $1,632/lung cancer death
4 Diagnosis of Lung Cancer Signs and Symptoms Cough (especially with blood), fevers, weight loss, facial swelling, pain, etc. Scans CXRAY CT PET Tests Blood Bronchoscopies Biopsies
7 Next Generation Scanners Can See a Pinhead-Size Spot Prototypes capable of 1mm resolution Scanning within a breath Look deep inside the lung Image Courtesy of Dianna Cody, MDAH Kiessling et al, Nature Med online, 9/7/2004
8 How Do You Study Lung Cancer? Microscopy Cellular biology Genetics Proteomics
9 Lung Cancer Anatomy Silverberg, 3rd ed
10 Lung Cancer- Histology SCLC
11 ADENOCARCINOMA SQUAMOUS CELL CARCINOMA NSCLC LARGE CELL CARCINOMA BAC
12 Normal Cells
13 Cancer Cells
15 Mutations in the EGFR, erbb-2 and MET Gene in Lung Cancer EGFR Tyrosine kinase domain L858R L861Q R776C dele746-a750 dell747-p753inss dell747-t751inss dels752-i759 G719C ErbB-2 Tyrosine kinase domain ins779(vgs) ins774(ayvm) L755P SEMA PSI domain MET JM Tyrosine kinase domain N375S S323G L229F *E168D del 141bp *IVS 13-(52-53)insCT S1058P *T1010I *R988C
16 Laser Microdissection-Assisted Sequencing Before During After
17 EGFR Expressing Adenocarcinoma NSCLC EGFR
18 EGFR Mutations in LCM-Tumor Cells (Hilar LN)
19 Lumbar Puncture: CSF NSCLC Leukocyte CSF
20 EGFR Mutations in LCM-Tumor Cells (CSF)
21 Tumor Tissue Microarray University of Chicago TMA
24 Therapy for Lung Cancer Surgery Radiation Therapy Chemotherapy Novel Targeted Therapies
25 Breakthroughs in the Treatment of Lung Cancer
26 Adjuvant Therapy for Lung Cancer Adjuvant therapy treatment (e.g. chemotherapy) after surgery to eradicate microscopic residual cancer and prevent cancer recurrence 5 Large Studies have shown that Adjuvant Chemotherapy can increase cure rate in lung cancer
27 Drugs Recently Approved for Advanced Non-Small Cell Lung Cancer Gefitinib (Iressa) May 2003 (withdrawn July 2005) Pemetrexed (ALIMTA) February 2004 Erlotinib (Tarceva) November 2004 Bevacizumab (Avastin) October 2006
28 Pemetrexed Chemotherapy approved for mesothelioma and lung cancer Given IV, usually with platinum Does not cause hair loss Vitamin B12 and folic acid need to be taken with it.
29 Erlotinib Oral EGFR tyrosine kinase inhibitors Have activity in non-small-cell lung cancer (~10-15% of tumors will shrink; ~30-40% will be stable) Tarceva improves survival in patients with metastatic disease that have failed first-line chemotherapy Occasional dramatic and durable tumor responses are seen
30 Tarceva Targets a receptor found in lung cancer Taken by mouth Less side effects (no hair loss or nausea) Rash and diarrhea seen
31 How Does Tarceva Work?
32 Tumor Shrinkage with Tarceva:
33 Normal and Tumor Vasculature Normal Blood Vessels Tumor Blood Vessels Maturation factors present (eg, Ang-1) Less dependent on cell survival factors Less permeable 3 Supporting cells present 2 Reduced integrin expression Growth and survival factors (eg, VEGF, bfgf) present 2. Leaky Fewer supporting cells 2 Preferential expression of α v β 3, α v β 5, and α 5 β 1 integrins 1 1. Griffioen and Molema. Pharmacol Rev. 2000;52: Blau and Banfi. Nat Med. 2001;7: Jain. Nat Med. 2001;7:987.
35 Future for Lung Cancer with Effective Research In the future, we will have routine: Scans Blood tests Bronchoscopy/Sputum tests Family screens In the future, we will have better: Prevention Diagnosis Ability Surgery Radiation Therapy Chemotherapy (Including Novel Therapies)
36 If you want to change the world, be that change. --Mahatma Gandhi
Lung Cancer and Mesothelioma Robert Kratzke, M.D. John C. Skoglund Professor of Lung Cancer Research Section of Heme/Onc/Transplant Department of Medicine University of Minnesota Medical School Malignant
The Use of Kinase Inhibitors: Translational Lab Results Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma Sheelu Varghese, Ph.D. H. Richard Alexander, M.D.
LUNG CANCER POPULATION STATUS & TREATMENT OPTIONS By: Sweety Narang, RTT & Gurpreet Sandhu, RTT OVERVIEW 1. Statistics on Lung Cancer Incidence & Mortality 2. Functions of the Lung 3. Etiology & Risk Factors
National Cancer Institute What You Need To Know About Thyroid Cancer U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute Services This is only one of many
Molecular Pathogenesis of Malignant Pleural Mesothelioma 1 Philip A. Rascoe, Xiaobo X. Cao and W. Roy Smythe Texas A&M Health Science Center College of Medicine, Scott & White Memorial Hospital & Clinic,
South East London Cancer Network Lung Tumour Working Group Clinical Guidelines 2012 1. Aims of Lung Tumour Working Group South East London Cancer Network...1 Lung Tumour Working Group Clinical Guidelines
Lung Cancer Education Program November 23, 2013 Lung Cancer: More than meets the eye Shantanu Banerji MD, FRCPC Presenter Disclosure Faculty: Shantanu Banerji Relationships with commercial interests: Grants/Research
Principal Principal Investigator s Investigator Organization Project Title Alan Pollack University of Miami Integrated Biomarker Profiling for Individualized Prostate Cancer Therapy General Project Abstract
Open Clinical Trials for Mesothelioma Video-Assisted Surgery or Talc Pleurodesis in Treating Patients with Malignant Mesothelioma STUDY ID: NCT00821860 STUDY PURPOSE: Video-assisted surgery to remove part
""Corresponding author of the Fifth Nimotuzumab Global Meeting The Center for Molecular Immunology (CIM) celebrated its 15 th anniversary with a highly attended international workshop: Fifth Nimotuzumab
Cancer Treatment & Survivorship Facts & Figures 14-15 Estimated Numbers of Cancer Survivors by State as of January 1, 14 OR 185,73 CA 1,661,74 WA 332,9 NV 18, ID 66,6 UT 81,26 MT 52,3 WY 29,8 CO 211,67
SELECTIVE SCREENING OF LUNG CANCER CASES Steven Laird Laird & Jones, L.L.P. 2400 Scott Avenue Fort Worth, Texas 76103-2245 817-531-3000 Lung cancer is the number one cancer killer of American men and women.
Cancer Consult Taussig Cancer Institute Summer 2013 Nanotechnology: Small Particles Make Huge Impact on Cancer Medicine Also inside: Highlights from the American Society for Clinical Oncology Annual Meeting
RESEARCH EDUCATE ADVOCATE Just Diagnosed with Melanoma Now What? INTRODUCTION If you are reading this, you have undergone a biopsy (either of a skin lesion or a lymph node) or have had other tests in which
What is Mesothelioma? Mesothelioma is a rare type of cancer that develops in the mesothelial cells found in one s body. These cells form membranous linings that surround and protect the body s organs and
Colorectal Cancer Overview The information that follows is based on the more detailed information in our document, Colorectal Cancer. What is cancer? The body is made up of trillions of living cells. Normal
Sex-Specific Medical Research Why Women s Health Can t Wait A Report of the Mary Horrigan Connors Center for Women s Health & Gender Biology at Brigham and Women s Hospital The Connors Center for Women
Special Section: Cancer in Children & Adolescents Overview The news of a cancer diagnosis is never welcome, but may be even more unexpected and difficult when the disease is diagnosed in a child or adolescent.
C U R E P R E S E N T S understanding mesothelioma u n d e r s t a n d i n g m e s o t h e l i o m a Copyright 2009 by CURE Media Group, L.P. Published by CURE Media Group 3102 Oak Lawn, Suite 610 Dallas,
Newer therapies may extend survival of some patients with malignant mesothelioma. Cut Cowrie_2441. Photograph courtesy of Henry Domke, MD. www.henrydomke.com. Malignant Pleural Mesothelioma: A Comprehensive
National Cancer Institute What You Need TM To Know About Melanoma and Other Skin Cancers U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute Services This
May 2015 Developments in Cancer Treatments, Market Dynamics, Patient Access and Value Global Oncology Trend Report 2015 Introduction A cluster of innovative medicines for patients with a wide variety of
Diagnosis and Treatment of Mesothelioma Webcast June 9, 2009 Anne Tsao, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of M. D. Anderson Cancer Center, its medical
National Cancer Institute What You Need To Know About Leukemia U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health How Can We Help? You may want information about cancer for yourself,
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Mesothelioma: Questions
Manchester Cancer Lung Pathway Board Annual Report 2013/14 Pathway Director: Dr Neil Bayman Pathway Manager: Miss Caroline McCall Executive summary 1. Manchester Cancer is an integrated cancer system for
Patient's Guide to Thoracic Cancer The Thoracic Oncology Program consists of an experienced team of nationally recognized cancer specialists experienced in the treatment of: Lung Cancer Tracheal Cancer